President Donald Trump’s executive order targeting DEI in federally funded programs is raising concerns for health systems that rely on research grants to advance patient care, medical innovation, and workforce diversity. Alongside a temporary funding freeze and increased scrutiny of federal grants, the order could disrupt health equity research, disease prevention, and AI bias studies, forcing institutions to reassess funding strategies.
The NIH and NSF stated they were reviewing their portfolios to comply with the order, leaving ongoing and future studies in limbo. Funding for chronic disease disparities, infectious diseases, and social determinants of health is now at risk, threatening critical advancements in patient care.
Beyond research, the order could shrink the pipeline of diverse healthcare professionals, as federally funded fellowships for underrepresented students come under scrutiny.
Potential Impacts on Health Systems:
- Disruptions in health equity research on chronic diseases, infectious diseases, and social determinants of health.
- Financial strain on academic medical centers as key NIH and NSF grants face uncertainty.
- Workforce diversity challenges, limiting opportunities for underrepresented students in medicine and public health.
- Slower innovation in AI and clinical decision-making tools due to reduced funding for bias research.
As health systems navigate financial pressures, these policy shifts add another layer of uncertainty. Protecting research funding and workforce diversity is critical to sustaining innovation, equity, and patient care.